Hans Maier was recently elected to the board of directors of Ascelia Pharma AB. The Malmö-based pharmaceutical company focuses on developing specialty oncological products.
Official press release
Official press release
|
|
BGM News BlogWe regularly publish news from within our firm and our focus industries News categories
All
|